Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL

NCT04863742 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: Dextenza 0.4Mg Ophthalmic Insert
DRUG: Prednisolone Acetate

Sponsor

Sight Medical Doctors PLLC

Collaborators

[object Object]